38 articles
T-Mobile International challenged the refusal of its mobile-terminal patent under Section 3(m) of the Patents Act before the Delhi High Court. With no settled test in place, could…
When Shiv Nadar University's patent application was deemed abandoned over a four-day delay in replying to an examination report, the Delhi High Court had to decide whether Section…
NEC Corporation's appeal over the refusal of its video coding patent has been dismissed by the Delhi High Court, which confirmed that the invention lacks inventive step under…
Sulzer Mixpac appealed the rejection of its static mixer patent to the Delhi High Court, arguing its own prior patents did not anticipate the claimed design. The court…
Novo Nordisk A/S took Dr Reddy's Laboratories to the Delhi High Court over its Semaglutide patent, seeking to block generic imports of the anti-diabetic drug. Would the court…
Titan Company Limited took its rejected “Jewellery Assembly” application to the Madras High Court, testing whether a cost-saving gemstone arrangement was patent or design subject matter. Did the…
The Delhi High Court sets aside the Controller’s blanket refusal of an FTIR spectral analysis patent for skin cancer tissue characterization, holding that the Controller misapplied the Section…
The Delhi High Court's Division Bench held that product-to-claim mapping is indispensable for patent infringement, even in anticipatory suits. In a dispute between Zydus Lifesciences and E.R. Squibb…
Daewoong Pharmaceutical challenged the Controller's rejection of its crystalline SGLT inhibitor patent before the Delhi High Court. The core question: does improved dissolution and stability satisfy the Section…
Philip Morris Products S.A. challenged eight patent refusals at the Delhi High Court, each rejected by the Controller under Section 3(b) of the Patents Act on the ground…